Gene · 53335
Papers3,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations. | Eur J Hum Genet | 2025 | 39448799 | PubTator, text mining | PubMed |
| Conserved helical motifs in the IKZF1 disordered region mediate NuRD interaction and transcriptional repression. | Blood | 2025 | 39437550 | PubTator, text mining | PubMed |
| Distinct deregulation trends of transcriptional protein complexes in aging naive T cells. | J Leukoc Biol | 2025 | 39437255 | PubTator, text mining | PubMed |
| Fateful Decisions of Where to Cut the Line: Pathology Associated with Aberrant 3' End Processing and Transcription Termination. | J Mol Biol | 2025 | 39321865 | PubTator, text mining | PubMed |
| Nanobody engineering: computational modelling and design for biomedical and therapeutic applications. | FEBS Open Bio | 2025 | 38898362 | PubTator, text mining | PubMed |
| Hydroxyurea reduces the levels of the fetal globin gene repressors ZBTB7A/LRF and BCL11A in erythroid cells in vitro. | J Sick Cell Dis | 2024 | 40304012 | PubTator, text mining | PubMed |
| Enhanced fetal hemoglobin production via dual-beneficial mutation editing of the HBG promoter in hematopoietic stem and progenitor cells for β-hemoglobinopathies. | Stem Cell Res Ther | 2024 | 39736768 | PubTator, text mining | PubMed |
| Editorial: What does experimental pharmacology and drug discovery look like in 2035? | Front Pharmacol | 2024 | 39679369 | PubTator, text mining | PubMed |
| Cell-specific delivery of CRISPR-Cas9 with pseudotyped lentiviral particles: Just change the envelope. | Mol Ther Nucleic Acids | 2024 | 39669702 | PubTator, text mining | PubMed |
| A finger that gets in the way: When binding isn't just about the bound state. | Structure | 2024 | 39642848 | PubTator, text mining | PubMed |
| Cross-species single-cell analysis reveals divergence and conservation of peripheral blood mononuclear cells. | BMC Genomics | 2024 | 39623297 | PubTator, text mining | PubMed |
| A catalog of gene editing sites and genetic variations in editing sites in model organisms. | BMC Genomics | 2024 | 39614172 | PubTator, text mining | PubMed |
| A tetramer of BCL11A is required for stable protein production and fetal hemoglobin silencing. | Science | 2024 | 39607926 | Swiss-Prot, curated | PubMed |
| BCL11A expression worsens the prognosis of DLBCL and its co-expression with C-MYC predicts poor survival. | Pathol Res Pract | 2024 | 39546996 | PubTator, text mining | PubMed |
| Associations between BCL11A and HBS1L-MYB polymorphisms and thalassemia risk. | J Taibah Univ Med Sci | 2024 | 39534793 | PubTator, text mining | PubMed |
| DNA regulatory element cooperation and competition in transcription. | BMB Rep | 2024 | 39523506 | PubTator, text mining | PubMed |
| Identification of small molecule agonists of fetal hemoglobin expression for the treatment of sickle cell disease. | PLoS One | 2024 | 39504332 | PubTator, text mining | PubMed |
| A mutant BCL11B-N440K protein interferes with BCL11A function during T lymphocyte and neuronal development. | Nat Immunol | 2024 | 39487351 | PubTator, text mining | PubMed |
| Structural insights into the DNA-binding mechanism of BCL11A: The integral role of ZnF6. | Structure | 2024 | 39423807 | Swiss-Prot, curated | PubMed |
| Zinc finger nuclease-mediated gene editing in hematopoietic stem cells results in reactivation of fetal hemoglobin in sickle cell disease. | Sci Rep | 2024 | 39414860 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53335/papers?page=9